Wednesday, March 22, 2023 3:26:59 PM
My worry is how they get the funding as most...or partner with JnJ etc :)
can they do that with 210 data show what Bmt u etc thinks.. Good Data.or what left from the 4.3 m or whatever to only get high rishk, lol. I mean chit they got 23m funding for trial which is about 70% done. so maybe they got 3m left to finish,,,not enough if you see 20m only got 70% of the trial done.
Ps. Holding because of the science and a few smart DD people :)
pps. lol can someone delete one of same post well damn this northern lights vape has me to realaxed
can they do that with 210 data show what Bmt u etc thinks.. Good Data.or what left from the 4.3 m or whatever to only get high rishk, lol. I mean chit they got 23m funding for trial which is about 70% done. so maybe they got 3m left to finish,,,not enough if you see 20m only got 70% of the trial done.
Ps. Holding because of the science and a few smart DD people :)
pps. lol can someone delete one of same post well damn this northern lights vape has me to realaxed
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
